Case File
efta-02149415DOJ Data Set 10OtherEFTA02149415
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02149415
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
R
ilv
From:
Sent:
on
:53:01 PM
Subject: Re: Jeffrey Epstein
Let's do 4:30. Thank you for all your help.
Sent from my iPhone
On Feb 11, 2013, at 7:48 AM, Rosa da Silva
wrote:
> Jes is free at 10 AM or 4:30 PM. Our cross streets are 48th & 49th Sts. Thanks,
Rosa
•
Original Message
> From:
> Sent: Mon ay, Fe ruary
,
:
AM
> To: Rosa da Silva
> Subject: Re: Jeffrey Epstein
> Let's do wed. What time is good for Jes? Will this be at
What are the cross streets there?
> Sent from my iPhone
> On Feb 11, 2013, at 6:55 AM, Rosa da Silva
wrote:
» Good morning
Wed or Thurs are best for Jes. Please let me know if this
works for Darre .
>>
» Thanks,
>> Rosa
>>
Original Message
» From:
>> Sent: Friday, February 08,
:
PM
» To: Rosa da Silva
» Subject: Jeffrey Epstein
>>
» Hi Rosa. Hope all is well at your new endeavor with Jes! Darren is asking if
he could set up an appt with Jes sometime next week so he can sign Jeffrey's
trust documents. Anytime that is convenient for Jes just let me know. Thanks,
>> Sent from my iPhone
>> This e-mail is intended only for the person or entity to which it is addressed
and may contain confidential and/or privileged material. Any review,
retransmission, dissemination or other use of, or taking of any action in
reliance upon, the information in this e-mail by persons or entities other than
the intended recipient is prohibited and may be unlawful. If you received this in
error, please contact the sender and delete the material from any computer.
>> This communication is for informational purposes only. It is not intended as
and does not constitute an offer or solicitation for the purchase or sale of any
financial instrument or as an official confirmation of any transaction. All
market prices, data and other information are not warranted as to completeness or
EFTA_R1_00809331
EFTA02149415
accuracy and are subject to change without notice. Any expected returns are
provided for illustrative purposes only and are not intended to serve as, and
must not be relied upon by any prospective investor as, a guaranty, an assurance,
a prediction of a definitive statement of fact or a probability. Investment in
funds managed by BlueMountain carries certain risks, including the risk of loss
of principal. Unless indicated otherwise, performance results are presented net
of fees and expenses. Certain market and economic events having an impact on
performance may not repeat themselves. Any comments or statements made herein do
not necessarily reflect those of BlueMountain Capital Management, LLC or its
affiliates. PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS AND
NO REPRESENTATION IS MADE THAT RESULTS SIMILAR TO THOSE SHOWN CAN BE ACHIEVED.
> This e-mail is intended only for the person or entity to which it is addressed
and may contain confidential and/or privileged material. Any review,
retransmission, dissemination or other use of, or taking of any action in
reliance upon, the information in this e-mail by persons or entities other than
the intended recipient is prohibited and may be unlawful. If you received this in
error, please contact the sender and delete the material from any computer.
> This communication is for informational purposes only. It is not intended as
and does not constitute an offer or solicitation for the purchase or sale of any
financial instrument or as an official confirmation of any transaction. All
market prices, data and other information are not warranted as to completeness or
accuracy and are subject to change without notice. Any expected returns are
provided for illustrative purposes only and are not intended to serve as, and
must not be relied upon by any prospective investor as, a guaranty, an assurance,
a prediction of a definitive statement of fact or a probability. Investment in
funds managed by BlueMountain carries certain risks, including the risk of loss
of principal. Unless indicated otherwise, performance results are presented net
of fees and expenses. Certain market and economic events having an impact on
performance may not repeat themselves. Any comments or statements made herein do
not necessarily reflect those of BlueMountain Capital Management, LLC or its
affiliates. PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS AND
NO REPRESENTATION IS MADE THAT RESULTS SIMILAR TO THOSE SHOWN CAN BE ACHIEVED.
EFTA_R1_00809332
EFTA02149416
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2149415Phone
2149416Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.